Margriet Kwint

Outcome of treatment of synchronous oligometastases 65 3 Reference 1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA: a cancer journal for clinicians 2015;65:87-108. 2. Walters S, Maringe C, Coleman MP, et al. Lung cancer survival and stage at diagnosis in australia, canada, denmark, norway, sweden and the uk: A population-based study, 2004- 2007. Thorax 2013;68:551-564. 3. Group NM-AC. Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: A systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26:4617-4625. 4. Hellman S, Weichselbaum RR. Oligometastases. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13:8-10. 5. Weichselbaum RR, Hellman S. Oligometastases revisited. Nature reviews Clinical oncology 2011;8:378-382. 6. Baker S, Dahele M, Lagerwaard FJ, et al. A critical review of recent developments in radiotherapy for non-small cell lung cancer. Radiation oncology 2016;11:115. 7. Ashworth A, Rodrigues G, Boldt G, et al. Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature. Lung cancer 2013;82:197-203. 8. Kim C, Hoang CD, Kesarwala AH, et al. Role of local ablative therapy in patients with oligometastatic and oligoprogressive non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2017;12:179-193. 9. Ashworth AB, Senan S, Palma DA, et al. An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer. Clinical lung cancer 2014;15:346-355. 10. De Rose F, Cozzi L, Navarria P, et al. Clinical outcome of stereotactic ablative body radiotherapy for lung metastatic lesions in non-small cell lung cancer oligometastatic patients. Clinical oncology 2016;28:13-20. 11. De Ruysscher D, Wanders R, van Baardwijk A, et al. Radical treatment of non-small- cell lung cancer patients with synchronous oligometastases: Long-term results of a prospective phase ii trial (nct01282450). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7:1547-1555. 12. Downey RJ, Ng KK, Kris MG, et al. A phase ii trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis. Lung cancer 2002;38:193-197. 13. Flannery TW, Suntharalingam M, Regine WF, et al. Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgery. International journal of radiation oncology, biology, physics 2008;72:19-23. 14. Gomez DR, Blumenschein GR, Jr., Lee JJ, et al. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: A multicentre, randomised, controlled, phase 2 study. The Lancet Oncology 2016.